The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index.
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
Open accessAbstract
Background—: Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding. Methods and Results—: All 182 678 subjects with atrial fibrillation in the Swedish Hospital Discharge Register were studied for an average of 1.5 years (260 000 patient-years at risk). Patients were stratified according to risk scores with the use of historic International Classification of Disease diagnostic codes in the register. Information about medication was obtained from the Swedish Drug Registry. Our primary end point was net benefit defined as number of avoided ischemic strokes with anticoagulation minus the number of excess intracranial bleedings with a weight of 1.5 to compensate for the generally more severe outcome with intracranial bleedings. The adjusted net clinical benefit favored anticoagulation for almost all atrial fibrillation patients. The exceptions were patients at very low risk of ischemic stroke with a CHA 2 DS 2 -VASc score of 0 and moderately elevated bleeding risk (−1.7%/y). The results were broadly similar with CHADS 2 , except for patients with very low embolic risk; the CHA 2 DS 2 -VASc was able to identify those patients (n=6205, 3.9% of all patients) who had no net clinical benefit or even some disadvantage from anticoagulant treatment. Conclusions—: In almost all patients with atrial fibrillation, the risk of ischemic stroke without anticoagulant treatment is higher than the risk of intracranial bleeding with anticoagulant treatment. Analysis of the net benefit indicates that more patients may benefit from anticoagulant treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“initial uptake of the intervention was 99.4%”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
In the citing paper
“These factors resulted in a total health care cost of $96”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
In the citing paper
“this issue was addressed by instead performing a thorough cost accounting from 2 specific exemplar interventions.30,31”
From Accuracy requirements for cost-effective suicide risk prediction among primary care patients in the US (2021) · cites this paper as [30]
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Self-citationGuidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
Self-citationExternal review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 3×
“Frequent falls, n (%) 9294 (10) 2647 (4) 0.”
Self-citation
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- 10.1001/archinte.1996.00440040081009 · DOI
Cited by
Sorted by citations
Items 201–300 of 455
Wu, C. M., McMurtry, M. S., Sandhu, R. K., Youngson, E. R. E., Ezekowitz, J. A., Kaul, P., & McAlister, F. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140607 · Cited by 14
Ali, M. S., Mba, B. I., Ciftci, F. D., & Ali, A. S. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-215731 · Cited by 14
Humbert, X., Roule, V., Chequel, M., Fédrizzi, S., Brionne, M., Lelong‐Boulouard, V., Milliez, P., & Alexandre, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.212 · Cited by 14
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future
Wehbe, R. M., & Yadlapati, A. (2016) · Texas Heart Institute Journal · doi:10.14503/thij-16-5785 · Cited by 14
Roldan, T., Blanco, J. J. R., Villamañán, E., & Waxman, A. B. (2017) · Pulmonary Circulation · doi:10.1177/2045893217721903 · Cited by 14
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on reversal agents
Fusco, S. A. D., Lucà, F., Benvenuto, M., Iorio, A., Fiscella, D., D’Ascenzo, F., Madeo, A., Colivicchi, F., Lenarda, A. D., & Gulizia, M. M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.060 · Cited by 14
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.06.003 · Cited by 14
Self-citationAtrial fibrillation and stroke prevention: brief observations on the last decade
Lip, G. Y. H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.896196 · Cited by 14
Self-citationUchiyama, S., Hori, M., Matsumoto, M., Tanahashi, N., Momomura, S., Goto, S., Izumi, T., Koretsune, Y., Kajikawa, M., Kato, M. C., et al. (2013) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2013.10.001 · Cited by 13
Huber, K., Lip, G. Y. H., & Marín, F. R. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0677 · Cited by 13
Self-citationThe Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation
Ha, A. C. T., & Healey, J. S. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.06.001 · Cited by 13
Pallazola, V. A., Kapoor, R. K., Kapoor, K., McEvoy, J. W., Blumenthal, R. S., & Gluckman, T. J. (2019) · Vascular Medicine · doi:10.1177/1358863x18819816 · Cited by 14
Wong, C. K., Huang, D., Zhou, M., Hai, J. J., Yue, W. S., Li, W., Yin, L., Zuo, M., Feng, Y., Tan, N., et al. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137916 · Cited by 13
Recent advances in the management of transient ischemic attacks
Ortiz-Garcia, J., Gomez, C. R., Schneck, M. J., & Biller, J. (2022) · Faculty Reviews · doi:10.12703/r/11-19 · Cited by 14
La anticoagulación oral en el anciano con fibrilación auricular no valvular
Fernández, F. V., Jiménez, M. D. R. M., Cerviño, S. M. B., & Losada, M. D. M. M. (2015) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2015.01.005 · Cited by 13
Cairns, J. A., & McMurtry, M. S. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.006 · Cited by 12
Kea, B., Waites, B. T., Lin, A. L., Raitt, M. H., Vinson, D. R., Ari, N., Welle, L., Sill, A. P., Button, D. A., & Sun, B. (2020) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2020.3.45135 · Cited by 12
Ineligibility for Anticoagulation in Patients with Atrial Fibrillation
Conde, I. D., & Halperin, J. L. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.07.001 · Cited by 12
Watanabe, E., Yamamoto, M., Kodama, I., Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Lip, G. Y. H., Kodani, E., Okuyama, Y., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.008 · Cited by 12
Self-citationGiner‐Soriano, M., Roso‐Llorach, A., Urgell, C. V., Cervelló, X. C., Capellà, D., González, I. F., Elorza, J. M., Casajuana‐Closas, M., Troncoso‐Mariño, A., Diogène, E., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4137 · Cited by 12
Bleeding Risk Assessment in Patients With Atrial Fibrillation Who Are Taking Oral Anticoagulants
Guo, Y., Lip, G. Y. H., & Apostolakis, S. Z. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1012 · Cited by 12
Self-citationAtrial fibrillation in cancer: thromboembolism and bleeding in daily practice
Chu, G. K. T., Seelig, J., Cannegieter, S. C., Gelderblom, H. A. J., Hovens, M. M. C., Huisman, M. V., van der Hulle, T., Trines, S. A. I. P., Vlot, A. J., Versteeg, H. H., et al. (2023) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2023.100096 · Cited by 11
Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation
Zoppellaro, G., Granziera, S., Jose, S. P., Denas, G., Bracco, A., Iliceto, S., & Pengo, V. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1024222 · Cited by 11
How I use anticoagulation in atrial fibrillation
Steinberg, B. A. (2016) · Blood · doi:10.1182/blood-2016-07-693614 · Cited by 11
Pappas, M. A., Barnes, G. D., & Vijan, S. S. (2017) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3932-7 · Cited by 11
An Update on Anticoagulation in Atrial Fibrillation
Amerena, J. V., & Ridley, D. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.131 · Cited by 11
Atrial fibrillation detection with a portable device during cardiovascular screening in primary care
Diamantino, A. C., Nascimento, B. R., Beaton, A., Nunes, M. C. P., Oliveira, K., Rabelo, L. C., Barbosa, M. M., Tompsett, A., Olivieri, L., Mata, M. D. O., et al. (2020) · Heart · doi:10.1136/heartjnl-2019-316277 · Cited by 11
Menichelli, D., Ettorre, E., Pani, A., Violi, F., Pignatelli, P., & Pastori, D. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.02.002 · Cited by 11
Olsson, L. G., Swedberg, K., Lappas, G., Stewart, S., & Rosengren, A. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.028 · Cited by 10
Ruiz-Nodar, J. M., Marín, F. R., & Lip, G. Y. H. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.07.018 · Cited by 10
Self-citationGullón, A., Suárez, C., Díez‐Manglano, J., Formiga, F., Cepeda, J. M., Pose, A., Camafort, M., Castiella, J., Rovira, E. R., & Mostaza, J. M. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.10.052 · Cited by 10
Eggebrecht, L., Ludolph, P., Göbel, S., Panova‐Noeva, M., Arnold, N., Nagler, M., Bickel, C., Lauterbach, M., Hardt, R., Cate, H. T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-82076-9 · Cited by 10
Chichareon, P., Winijkul, A., Lip, G. Y. H., & Krittayaphong, R. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15716 · Cited by 10
Self-citationGuan, L., Han, S., Johnston, S. C., Bath, P. M., Amarenco, P., Yang, Y., Wang, T., Jing, J., Wang, C., Gao, Y., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209845 · Cited by 10
Lin, H.-C., Tsai, W., Lin, J., Chang, W., Huang, C., Wang, H., Kung, C., Su, C.-M., Su, Y., Lin, W.-C., et al. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.07.045 · Cited by 10
Monitoring risk and preventing ischemic stroke in the very old
Delgardo, M. W., Rabin, G., Tudor, T., Tang, A. J., Reeves, G., & Connolly, E. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2244674 · Cited by 11
Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.021 · Cited by 11
Self-citationTiili, P., Jukka Putaala, A., Mehtälä, J., Khanfir, H., Niiranen, J., Korhonen, P. A., Raatikainen, P. M. J., & Lehto, M. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-0975 · Cited by 10
Anticoagulation in pulmonary arterial hypertension: a decision analysis
Jose, A., Eckman, M. H., & Elwing, J. (2019) · Pulmonary Circulation · doi:10.1177/2045894019895451 · Cited by 10
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failure
Boos, C. J., Nam, M. C. Y., & Camm, A. J. (2013) · Heart Failure Reviews · doi:10.1007/s10741-013-9398-3 · Cited by 9
Cohen, J. E., Gomori, J. M., Honig, A., & Leker, R. R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225242 · Cited by 9
Ahmad, Y., & Lip, G. Y. H. (2013) · Contributions to nephrology · doi:10.1159/000346726 · Cited by 9
Self-citationAntithrombotic and Anticoagulant Therapy for Atrial Fibrillation
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Cardiology Clinics · doi:10.1016/j.ccl.2014.07.009 · Cited by 10
Self-citationStroke prevention in atrial fibrillation: changing concepts
Lip, G. Y. H. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvu003 · Cited by 9
Self-citationRenoux, C., Coulombe, J., & Suissa, S. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0269-4 · Cited by 9
Coleman, C. I., Yuan, Ž., Schein, J. R., Crivera, C., Ashton, V., Laliberté, F., Lefèbvre, P., & Peterson, E. D. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1297932 · Cited by 9
Sciera, L. K., Frost, L., Dybro, L., & Poulsen, P. B. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa092 · Cited by 9
Wallerstedt, S. M., & Hoffmann, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13206 · Cited by 9
Patients With Atrial Fibrillation and a CHA2DS2-VASc Score of 1
Huisman, M. V. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.010 · Cited by 9
Brant, L. C. C., Ribeiro, A. H., Eromosele, O. '. B., Filho, M. M. P., Barreto, S. M., Duncan, B. B., Larson, M. G., Benjamin, E. J., Ribeiro, A. L. P., & Lin, H. (2025) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.125.013734 · Cited by 10
Giner‐Soriano, M., Urgell, C. V., Roso‐Llorach, A., Morros, R., Capellà, D., Cervelló, X. C., González, I. F., Troncoso‐Mariño, A., Diogène, E., Elorza, J. M., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010144 · Cited by 8
Andersson, T., Magnuson, A., Bryngelsson, I., Fröbert, O., Henriksson, K. M., Edvardsson, N. G., & Poçi, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176846 · Cited by 8
Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
Wu, V. C., Huang, Y., Chen, S., Liu, C., Chang, C., Chen, C., Chang, S., Lin, M., Lee, T., Chen, M., et al. (2021) · Medicine · doi:10.1097/md.0000000000026945 · Cited by 8
Zhang, Y., Peng, W., Shi, X., Han, J., Wang, Y., Fang, Z., & Yang, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.859962 · Cited by 8
Dzeshka, M. S., & Lip, G. Y. H. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.973847 · Cited by 8
Self-citationSelecting antithrombotic therapy for patients with atrial fibrillation
Tanaka‐Esposito, C., & Chung, M. K. (2014) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.140002 · Cited by 8
Warfarin in non-valvular atrial fibrillation
Dalby, A. J., Wessels, P., & Opie, L. H. (2013) · South African Medical Journal · doi:10.7196/samj.7172 · Cited by 8
Senoo, K., Lane, D. A., & Lip, G. Y. H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.11.196 · Cited by 8
Self-citationLi, G., Holbrook, A. M., Delate, T., Witt, D. M., Levine, M., & Thabane, L. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009518 · Cited by 8
Management of atrial fibrillation and concomitant coronary artery disease
Martin, R. I. R., & Bates, M. G. D. (2017) · Continuing Cardiology Education · doi:10.1002/cce2.55 · Cited by 8
Isolated Hemopericardium after Initiation of Rivaroxaban: Implications and Potential Mechanisms
Mehta, A., Burkland, D. A., & Mathuria, N. S. (2019) · Clinics and Practice · doi:10.4081/cp.2019.1096 · Cited by 8
Atrial fibrillation and anticoagulation in patients with breast cancer
D’Souza, M., Smedegaard, L., Madelaire, C., Bang, C. N., Nielsen, D. L., Torp-Pedersen, C. T., Gislason, G., Schou, M., & Fosbøl, E. L. (2019) · Scandinavian Cardiovascular Journal · doi:10.1080/14017431.2019.1638517 · Cited by 8
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures
Fusco, S. A. D., Lucà, F., Benvenuto, M., Iorio, A., Fiscella, D., D’Ascenzo, F., Madeo, A., Colivicchi, F., Lenarda, A. D., & Gulizia, M. M. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.061 · Cited by 8
Tiili, P., Lehto, M., Halminen, O., Haukka, J. K., Lehtonen, O., Linna, M., Satopää, J., Korja, M., Niemela, M. R., Kinnunen, J., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.040360 · Cited by 7
Antithrombotic therapy for atrial fibrillation in hereditary hemorrhagic telangiectasia
Virk, Z. M., Richardson, T. L., & Al-Samkari, H. T. (2023) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-023-02839-1 · Cited by 7
A Standardized Bleeding Risk Score Aligns Anticoagulation Choices with Current Evidence
Berger, A. S., Dunn, A. S., & Kelley, A. S. (2014) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000017 · Cited by 7
The Year in Review of Clinical Cardiac Electrophysiology
Marcus, G. M., Keung, E. C., & Scheinman, M. M. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.062 · Cited by 7
Strategies for Maintaining Brain Health: The Role of Stroke Risk Factors Unique to Elderly Women
Manwani, B., Finger, C. E., & Lisabeth, L. D. (2022) · Stroke · doi:10.1161/strokeaha.121.036894 · Cited by 7
O’Shea, C., Brooks, A. G., Middeldorp, M. E., Harper, C., Hendriks, J., Russo, A. M., Freeman, J. V., Gopinathannair, R., Varma, N., Deering, T. F., et al. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01481-4 · Cited by 7
Escalas de evaluación del riesgo tromboembólico y hemorrágico en la fibrilación auricular
Copete, J. P., Esteve‐Pastor, M. A., Roldán, V., Valdés, M., & Marín, F. R. (2016) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(16)30011-5 · Cited by 7
Mochalina, N., Isma, N., Svensson, P. J., Själander, A., Carlsson, M., Juhlin, T., & Wieloch, M. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.08.004 · Cited by 7
Serious hemorrhages after ischemic stroke or TIA – Incidence, mortality, and predictors
Ögren, J., Irewall, A.-L., Söderström, L., & Mooe, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195324 · Cited by 7
Yang, Y., Yuan, J., Fan, C., Pu, J., Fang, P., Ma, J., Guo, X., & Li, Y. (2015) · Heart and Vessels · doi:10.1007/s00380-015-0718-5 · Cited by 7
Hutchens, R., Hung, J., Briffa, T. G., & McQuillan, B. (2020) · Heart Lung and Circulation · doi:10.1016/j.hlc.2020.10.026 · Cited by 7
Miwa, K., Tanaka, K., Koga, M., Tanaka, K., Yakushiji, Y., Sasaki, M., Kudo, K., Shiozawa, M., Yoshimura, S., Ihara, M., et al. (2025) · Stroke · doi:10.1161/strokeaha.125.050859 · Cited by 6
Kadhim, H., Jansson, M., Själander, S., Sjögren, V., Björck, F., Renlund, H., Eriksson, M., Norrving, B. G., & Själander, A. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100960 · Cited by 6
Jung, M., Byeon, K., Kang, K., Park, Y. M., Hwang, Y. M., Lee, S. H., Jin, E., Roh, S., Kim, J. S., Ahn, J., et al. (2022) · Yonsei Medical Journal · doi:10.3349/ymj.2022.0157 · Cited by 6
Self-citationSafety and timing of early therapeutic anticoagulation therapy after craniotomy
Wilson, J. M., Shelvin, K., Lawhon, S. E., Crabill, G. A., Hayden, E. A., & Velander, A. J. (2024) · Surgical Neurology International · doi:10.25259/sni_887_2023 · Cited by 6
Manolis, A. A., Manolis, T. A., & Manolis, A. S. (2024) · Current Vascular Pharmacology · doi:10.2174/0115701611317504240910113003 · Cited by 6
Atrial Fibrillation: a Marker or Risk Factor for Stroke
Tatarsky, B. A., & Napalkov, D. A. (2023) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2023-01-06 · Cited by 6
Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
Kosar, L., Jin, M., Kamrul, R., & Schuster, B. G. (2012) · Europe PMC (PubMed Central) · Cited by 6
Cost-Effectiveness of Bridging Anticoagulation Among Patients with Nonvalvular Atrial Fibrillation
Pappas, M. A., Barnes, G. D., & Vijan, S. S. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4796-9 · Cited by 6
Lip, G. Y. H., Lanitis, T., Mardekian, J., Kongnakorn, T., Phatak, H. M., & Dorian, P. (2015) · Stroke · doi:10.1161/strokeaha.115.009995 · Cited by 6
Self-citationDing, W. Y., Harrison, S. L., Lane, D. A., & Lip, G. Y. H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14738 · Cited by 6
Self-citationOpstelten, W., van den Donk, M., Kuijpers, T., & Burgers, J. S. (2014) · European Journal of General Practice · doi:10.3109/13814788.2014.989986 · Cited by 6
Andrikopoulos, G. K. (2012) · PubMed · Cited by 6
Evaluation and care of a patient with new-onset atrial fibrillation
Moayedi, Y., Abdel-Qadir, H. M., & Dorian, P. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.130393 · Cited by 5
Kim, H.-K., Jung, H., Cho, J., Huh, S., Lee, J. M., & Kim, Y.-W. (2014) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2014.08.022 · Cited by 5
The Hemorrhagic Risk: How to Evaluate It
Fusco, S. A. D., Colivicchi, F., & Santini, M. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12146 · Cited by 5
Anselmino, M., Frea, S., Gili, S., Rovera, C., Morello, M., Jorfida, M., TEODORI, J., Perversi, J., Salvetti, I., Marra, W. G., et al. (2021) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.20.05215-9 · Cited by 5
Heger, L. A., Danzer, M., Bode, C., Hortmann, M., Duerschmied, D., Olivier, C. B., & Moser, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00414 · Cited by 5
Singh, S., Singh, J., Sethi, S., Kaur, T., Bhardwaj, A., Meena, M. K., & Singla, M. (2021) · International Journal of Applied and Basic Medical Research · doi:10.4103/ijabmr.ijabmr_135_21 · Cited by 5
Pappas, M. A., Vijan, S. S., Rothberg, M. B., & Singer, D. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199593 · Cited by 5
Management of atrial fibrillation: easy as ABC
Mahmood, M., & Lip, G. Y. H. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05824-x · Cited by 6
Self-citationGrymonprez, M., Steurbaut, S., Sutter, A. D., & Lahousse, L. (2020) · Open Heart · doi:10.1136/openhrt-2020-001465 · Cited by 5
Atrial Fibrillation and Stroke in Elderly Patients
Dang, G., Jahangir, I. A., Sra, J. S., Tajik, A. J., & Jahangir, A. (2016) · Journal of patient-centered research and reviews · doi:10.17294/2330-0698.1409 · Cited by 5
Net Clinical Benefit of Warfarin
Fuster, V., & Chinitz, J. S. (2012) · Circulation · doi:10.1161/circulationaha.112.102319 · Cited by 5
Jung, M., Byeon, K., Kang, K., Lee, W. S., Kim, S., Park, Y. M., Hwang, Y. M., Lee, S. H., Jin, E., Roh, S., et al. (2023) · Journal of Arrhythmia · doi:10.1002/joa3.12840 · Cited by 4
Self-citationBon usage d’apixaban : que retenir pour la pratique
Albaladejo, P., Deplanque, D., Fossati, F., Mahagne, M., Mismetti, P., Nguyên, P., Roy, P., Touzé, E., & Mourad, J. (2014) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2014.09.002 · Cited by 4
Andersson, P., & Löndahl, M. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316631395 · Cited by 4
Metadata
- Authors
- Friberg, L., Rosenqvist, M., & Lip, G. Y. H.
- Affiliations
- Birmingham City Hospital (GB)
- Danderyds sjukhus (SE)
- Venue
- Circulation
- Published
- 2012-05-15
- Volume
- 125
- Issue
- 19
- Pages
- 2298-2307
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2165762371
- Cited by
- 454
- References
- 38
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 9 · 2023: 14 · 2022: 16 · 2021: 28 · 2020: 31 · 2019: 33 · 2018: 26 · 2017: 30 · 2016: 57 · 2015: 50 · 2014: 54 · 2013: 57 · 2012: 24
- FWCI
- 38.08
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, warfarin, anticoagulation, net clinical benefit, ischemic stroke, intracranial hemorrhage, CHA2DS2-VASc score, CHADS2 score, stroke risk stratification, bleeding risk, hospital discharge registry
- MeSH terms
- Aged, Anticoagulants, Atrial Fibrillation, Cerebral Hemorrhage, Female, Follow-Up Studies, Humans, Male, Middle Aged, Registries, Risk Factors, Sweden, Warfarin, Cohort Studies, Incidence, Stroke, Intracranial Embolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
